TUCAN: Ultra-fast methylation-based classification of pediatric solid tumors and lymphomas
Jongmans, M.; van Tuil, M.; de Ruijter, E.; Hiemcke-Jiwa, L.; Flucke, U.; de Krijger, R.; Scheijde-Vermeulen, M.; Kusters, P.; van Ewijk, R.; Merks, H.; van Noesel, M.; Pages-Gallego, M.; Vermeulen, C.; Tops, B.; de Ridder, J.; Kester, L.
Show abstract
The high heterogeneity of pediatric cancers presents significant diagnostic challenges, underscoring the need for accurate classification. Although molecular profiling supports first-line diagnostics and guides treatment, it can delay final diagnosis. While Nanopore-based methylation analysis has enabled rapid CNS tumor diagnosis, its application to pediatric solid tumors and lymphomas has remained largely unexplored. We developed Tucan, a deep-learning classifier trained on 3,818 methylation array profiles representing 84 subtypes, designed to classify tumors from sparse Nanopore methylation data. In retrospective validation (n=514), Tucan generated confident predictions (CFT[≥] 0.7) within 30 minutes of sequencing in 385 cases, achieving 372 correct diagnoses (F1-score: 0.98). In prospective testing (n=74; 63 classifiable), 52 samples reached the confidence threshold with 96% accuracy, confirming the original diagnosis in 47 cases and correctly refining or revising it in three. Together, Tucan enables rapid, high-confidence molecular classification of pediatric solid tumors and lymphomas.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- cfTrack : Exome-wide mutation analysis of cell-free DNA to simultaneously monitor the full spectrum of cancer treatment outcomes: MRD, recurrence, and evolution 93%
- Cell-free urine- and plasma DNA mutational analysis predicts neoadjuvant chemotherapy response and outcome in patients with muscle invasive bladder cancer 92%
- Non-invasive multi-cancer detection using DNA hypomethylation of LINE-1 retrotransposons 91%
Similar papers in this journal
- Machine learning-based tissue of origin classification for cancer of unknown primary diagnostics using genome-wide mutation features 94%
- Partner-independent fusion gene detection by multiplexed CRISPR/Cas9 enrichment and long-read Nanopore sequencing 93%
- Artificial intelligence-based histopathology image analysis identifies a novel subset of endometrial cancers with distinct genomic features and unfavourable outcome 93%
Similar papers in this journal
- Detection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis using aneuploidy and mutation identification in plasma 94%
- Interrogating the Precancerous Evolution of Pathway Dysfunction in Lung Squamous Cell Carcinoma Using XTABLE 93%
- High risk glioblastoma cells revealed by machine learning and single cell signaling profiles 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.